Fig. 4
From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence
Responder rates according to decrease in weekly incontinence episodes (WIE) over study visits by gender. a Female (n = 34), b male (n = 5) and c all (n = 39) patients of the ITT set. R(100), R(50–99), R(20–49) and R(0–19), percentage of patients with decrease in WIE of 100%, 50–99%, 20–49% and 0–19%, respectively from baseline (V0) to post-implantation visits. ITT intention to treat, R response, V visit, V2, V3 and V4 1, 6 and 12 months post implantation